Table 2.
Participants’ laboratory results
| N | 30 | |||
|---|---|---|---|---|
| Baseline | Post-treatment | Change | Pa | |
| FxAbs (%)b | 12 (7–17) | 12 (7–16) | 0.01 (−0.05 to 0.03) | 0.50 |
| 25(OH)D (ng/ml) | 14.2 (11.5–18.5) | 49.3 (42.3–58.1) | 32.0 (27.5–40.6) | <0.001 |
| Calcium (mg/dl) | 9.0 (8.5–9.5) | 9.0 (8.5–9.2) | −0.0 (−0.3 to 0.1) | 0.82 |
| Albumin (g/dl) | 3.6 (3.4–3.8) | 3.6 (3.4–3.9) | 0.1 (−0.0 to 0.2) | 0.48 |
| Corrected calciumc | 9.3 (8.7–9.9) | 9.2 (8.8–9.6) | −0.2 (−0.3 to 0.4) | 0.53 |
| Phosphorus (mg/dl) | 5.9 (4.7–7.1) | 5.8 (4.7–6.6) | −0.5 (−1.3 to 0.7) | 0.25 |
| Parathyroid hormone (pg/ml) | 325 (218–552) | 376 (269–611) | 42 (−127 to 218) | 0.28 |
| 1,25(OH)2D (pg/ml) | 15.1 (10.5–18.8) | 20.5 (17.0–24.7) | 5.6 (1.9–11.1) | 0.002 |
Median (interquartile range).
a
P value for individual change from baseline to end of study (paired t test).
b
Calcium absorption fraction.
c
Corrected calcium=((0.8×(4.0−subject’s albumin))+subject’s serum calcium).